These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17707537)

  • 21. RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population.
    Jara L; Acevedo ML; Blanco R; Castro VG; Bravo T; Gómez F; Waugh E; Peralta O; Cabrera E; Reyes JM; Ampuero S; González-Hormazábal P
    Cancer Genet Cytogenet; 2007 Oct; 178(1):65-9. PubMed ID: 17889711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas.
    Klopfleisch R; Gruber AD
    Vet Pathol; 2009 May; 46(3):416-22. PubMed ID: 19176491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disease family history and modification of breast cancer risk in common BRCA2 variants.
    Seymour IJ; Casadei S; Zampiga V; Rosato S; Danesi R; Falcini F; Strada M; Morini N; Naldoni C; Paradiso A; Tommasi S; Schittulli F; Amadori D; Calistri D
    Oncol Rep; 2008 Mar; 19(3):783-6. PubMed ID: 18288416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential association of BRCA1 and BRCA2 genes with some breast cancer-associated genes in early and late onset breast tumors.
    Chunder N; Mandal S; Roy A; Roychoudhury S; Panda CK
    Ann Surg Oncol; 2004 Dec; 11(12):1045-55. PubMed ID: 15576832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Association of polymorphisms of N372H in BRCA2 gene and 135G/C in RAD51 gene and breast cancers].
    Hu R; Wei Y; Jiang WJ; Yao WX; Long QM; Zhang JH; Liang Y; Tang XL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):973-5. PubMed ID: 19253839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients.
    Kriege M; Seynaeve C; Meijers-Heijboer H; Collee JM; Menke-Pluymers MB; Bartels CC; Tilanus-Linthorst MM; van den Ouweland A; van Geel B; Brekelmans CT; Klijn JG
    Breast Cancer Res Treat; 2008 Sep; 111(2):303-11. PubMed ID: 17952592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study.
    Kotsopoulos J; Librach CL; Lubinski J; Gronwald J; Kim-Sing C; Ghadirian P; Lynch HT; Moller P; Foulkes WD; Randall S; Manoukian S; Pasini B; Tung N; Ainsworth PJ; Cummings S; Sun P; Narod SA;
    Cancer Causes Control; 2008 Dec; 19(10):1111-9. PubMed ID: 18509731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the role of BRCA1, BRCA2 and RAD51 as biomarkers for breast cancer.
    Ziogas D; Liakakos T; Lykoudis E; Fatourou E; Roukos DH
    Radiother Oncol; 2009 Jan; 90(1):161-2. PubMed ID: 18343512
    [No Abstract]   [Full Text] [Related]  

  • 29. Analysis of RAD51 polymorphism and BRCA1 mutations in Polish women with breast cancer.
    Romanowicz-Makowska H; Smolarz B; Zadrozny M; Kulig A
    Exp Oncol; 2006 Jun; 28(2):156-9. PubMed ID: 16837909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
    Milne RL; Osorio A; Cajal TR; Vega A; Llort G; de la Hoya M; Díez O; Alonso MC; Lazaro C; Blanco I; Sánchez-de-Abajo A; Caldés T; Blanco A; Graña B; Durán M; Velasco E; Chirivella I; Cardeñosa EE; Tejada MI; Beristain E; Miramar MD; Calvo MT; Martínez E; Guillén C; Salazar R; San Román C; Antoniou AC; Urioste M; Benítez J
    Clin Cancer Res; 2008 May; 14(9):2861-9. PubMed ID: 18451254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can genetic testing guide treatment in breast cancer?
    Tutt A; Ashworth A
    Eur J Cancer; 2008 Dec; 44(18):2774-80. PubMed ID: 19027287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic bases of the radiosensitivity of breast cancer].
    Delaloge S; Marsiglia H
    Cancer Radiother; 2005 Mar; 9(2):77-86. PubMed ID: 15820435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and in silico analysis of BRCA1 and BRCA2 variants.
    Tommasi S; Pilato B; Pinto R; Monaco A; Bruno M; Campana M; Digennaro M; Schittulli F; Lacalamita R; Paradiso A
    Mutat Res; 2008 Sep; 644(1-2):64-70. PubMed ID: 18694767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families.
    Hartikainen JM; Kataja V; Pirskanen M; Arffman A; Ristonmaa U; Vahteristo P; Ryynänen M; Heinonen S; Kosma VM; Mannermaa A
    Clin Genet; 2007 Oct; 72(4):311-20. PubMed ID: 17850627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer.
    Söderlund Leifler K; Asklid A; Fornander T; Stenmark Askmalm M
    J Cancer Res Clin Oncol; 2015 May; 141(5):797-804. PubMed ID: 25354554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer.
    Aaltonen K; Amini RM; Landberg G; Eerola H; Aittomäki K; Heikkilä P; Nevanlinna H; Blomqvist C
    Breast Cancer Res Treat; 2009 Jan; 113(1):75-82. PubMed ID: 18240019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of human BRCA2-RAD51 by molecular docking study.
    Wiwanitkit V
    Arch Gynecol Obstet; 2007 Dec; 276(6):625-7. PubMed ID: 17549502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.
    Metcalfe KA; Poll A; O'Connor A; Gershman S; Armel S; Finch A; Demsky R; Rosen B; Narod SA
    Clin Genet; 2007 Sep; 72(3):208-17. PubMed ID: 17718858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of lycopene on the proliferation of human breast cells and BRCA1 and BRCA2 gene expression.
    Chalabi N; Le Corre L; Maurizis JC; Bignon YJ; Bernard-Gallon DJ
    Eur J Cancer; 2004 Jul; 40(11):1768-75. PubMed ID: 15251168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.